Cardiol Therapeutics (CRDL) Free Cash Flow (2017 - 2026)
Cardiol Therapeutics (CRDL) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM Cardiol Therapeutics (CRDL) free cash flow is -$18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Cardiol Therapeutics (CRDL) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -2.91% |
| 3 Years TTM | +0.67% |
| 5 Years TTM | +10.25% |
| All Time TTM | +52.31% |
Annual Free Cash Flow change of Cardiol Therapeutics (CRDL)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$5.45M | -68.64% |
| 2025 | -$17M | -0.30% |
| 2024 | -$17M | -8.46% |
| 2023 | -$19M | -5.47% |
| 2022 | -$20M | +8.13% |
| 2021 | -$19M | +158.76% |
| 2020 | -$7.20M | -20.71% |
| 2019 | -$9.09M | +13.36% |
| 2018 | -$8.02M | +663.70% |
| 2017 | -$1.05M | N/A |
Comparison Cardiol Therapeutics (CRDL) five years free cash flow CAGR with competitors
Cardiol Therapeutics (CRDL) five years free cash flow CAGR is 10.21%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LNTH | Lantheus Holdings Inc | 89.22% | +773.55% |
| ORGO | Organogenesis Holdings Inc - Class A | 87.05% | +752.27% |
| HROW | Harrow Inc | 51.26% | +401.88% |
| SBFM | Sunshine Biopharma Inc | 46.84% | +358.57% |
| ANIP | ANI Pharmaceuticals Inc | 45.89% | +349.24% |
| ALKS | Alkermes plc | 36.06% | +253.07% |
| PCRX | Pacira BioSciences Inc | 27.91% | +173.28% |
| NBIX | Neurocrine Biosciences Inc | 25.83% | +152.92% |
| AMPH | Amphastar Pharmaceuticals Inc | 24.53% | +140.12% |
| COLL | Collegium Pharmaceutical Inc | 23.23% | +127.48% |
| ALVO | Alvotech | 21.39% | +109.46% |
| UTHR | United Therapeutics Corp | 12.12% | +18.64% |
| PAHC | Phibro Animal Health Corp - Class A | 6.13% | -39.97% |
| ZTS | Zoetis Inc - Class A | 4.90% | -52.08% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -71.36% |
| EOLS | Evolus Inc | 0.82% | -91.93% |
| BHC | Bausch Health Companies Inc | 0.61% | -93.99% |